MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 152 filers reported holding MANNKIND CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -22.0% | 111,326 | -23.2% | 0.00% | – |
| Q2 2023 | $590 | +7.3% | 144,871 | +8.0% | 0.00% | – |
| Q1 2023 | $550 | -24.7% | 134,136 | -3.2% | 0.00% | – |
| Q4 2022 | $730 | -99.8% | 138,566 | +4.0% | 0.00% | – |
| Q3 2022 | $412,000 | -8.6% | 133,194 | +12.6% | 0.00% | – |
| Q2 2022 | $451,000 | +9.7% | 118,267 | +5.9% | 0.00% | – |
| Q1 2022 | $411,000 | +1.0% | 111,716 | +20.0% | 0.00% | – |
| Q4 2021 | $407,000 | -4.5% | 93,091 | -5.0% | 0.00% | – |
| Q3 2021 | $426,000 | -19.9% | 97,993 | +0.3% | 0.00% | – |
| Q2 2021 | $532,000 | +48.2% | 97,693 | +6.5% | 0.00% | – |
| Q1 2021 | $359,000 | +176.2% | 91,707 | +120.9% | 0.00% | – |
| Q4 2020 | $130,000 | +348.3% | 41,518 | +170.8% | 0.00% | – |
| Q3 2020 | $29,000 | +7.4% | 15,329 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | +107.7% | 15,329 | +20.5% | 0.00% | – |
| Q1 2020 | $13,000 | -13.3% | 12,718 | +7.6% | 0.00% | – |
| Q4 2019 | $15,000 | – | 11,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 557,051 | $2,050,000 | 1.09% |
| 180 WEALTH ADVISORS, LLC | 1,369,904 | $4,877,000 | 1.06% |
| EMERALD ADVISERS, LLC | 5,675,539 | $20,886,000 | 0.80% |
| DG Capital Management, LLC | 1,035,693 | $3,811,000 | 0.76% |
| Parkman Healthcare Partners LLC | 675,403 | $2,485,000 | 0.73% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 4,358,087 | $16,038,000 | 0.71% |
| Avoro Capital Advisors LLC | 8,800,000 | $32,384,000 | 0.59% |
| Monarch Partners Asset Management LLC | 420,478 | $1,547,000 | 0.35% |
| Bruce & Co., Inc. | 395,073 | $1,453,000 | 0.30% |
| SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,557,000 | 0.23% |